BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 37122607)

  • 1. Effectiveness of
    Lemos FFB; de Castro CT; Calmon MS; Silva Luz M; Pinheiro SLR; Faria Souza Mendes Dos Santos C; Correa Santos GL; Marques HS; Delgado HA; Teixeira KN; Souza CL; Oliveira MV; Freire de Melo F
    World J Gastroenterol; 2023 Apr; 29(14):2202-2221. PubMed ID: 37122607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma.
    Dong G; Liu C; Ye H; Gong L; Zheng J; Li M; Huang X; Huang X; Huang Y; Shi Y; Yin W; Gao Z
    Int J Hematol; 2008 Dec; 88(5):516-523. PubMed ID: 18949449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta-analysis.
    Jung K; Kim DH; Seo HI; Gong EJ; Bang CS
    Helicobacter; 2021 Apr; 26(2):e12774. PubMed ID: 33400830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis.
    Xie YL; He CY; Wei SQ; Guan WJ; Jiang Z
    Chin Med J (Engl); 2020 Jun; 133(11):1337-1346. PubMed ID: 32452892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of non-
    Lemos FFB; Silva Luz M; Rocha Pinheiro SL; Teixeira KN; Freire de Melo F
    World J Gastroenterol; 2023 Aug; 29(32):4851-4859. PubMed ID: 37701138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
    Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
    Kuo SH; Cheng AL
    Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.
    Yepes S; Torres MM; Saavedra C; Andrade R
    World J Gastroenterol; 2012 Feb; 18(7):685-91. PubMed ID: 22363141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL).
    Alpen B; Röbbecke J; Wündisch T; Stolte M; Neubauer A
    Ann Hematol; 2001; 80 Suppl 3():B106-7. PubMed ID: 11757689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
    Wündisch T; Dieckhoff P; Greene B; Thiede C; Wilhelm C; Stolte M; Neubauer A
    Gastroenterology; 2012 Oct; 143(4):936-42; quiz e13-4. PubMed ID: 22750463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.